Guangxi Investment Group Patents – Key Insights and Stats

Guangxi Investment Group has a total of 143 patents globally, out of which 105 have been granted. Of these 143 patents, more than 63% patents are active. China is where Guangxi Investment Group has filed all the patents. Parallelly, China seems to be the main focused R&D center and is also the origin country of Guangxi Investment Group.

Guangxi Investment Group was founded in the year 1988. Company is doing business in investment, financing and State-owned assets management. As of January 2022, Guangxi Investment Group has a market cap of $1.01 Billion.

Do read about some of the most popular patents of Guangxi Investment Group which have been covered by us in this article and also you can find Guangxi Investment Group’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Guangxi Investment Group’s patent portfolio.

How many patents does CEO of Guangxi Investment Group have?

The CEO, Zhou Lian has 0 patents.

How many patents does Guangxi Investment Group have?

Guangxi Investment Group has a total of 143 patents globally. These patents belong to 143 unique patent families. Out of 143 patents, 91 patents are active.

How many Guangxi Investment Group patents are Alive/Dead?

Worldwide Patents

Guangxi Investment Group Worldwide Legal Trends

Patent Families

Guangxi Investment Group Patent Portfolio

How Many Patents did Guangxi Investment Group File Every Year?

Guangxi Investment Group Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantGuangxi Investment Group Applications FiledGuangxi Investment Group Patents Granted
2011816
20121112
201355
201461
201572
2016410
2017192
20181115
2019159
2020108
2021610

How Many Patents did Guangxi Investment Group File in Different Countries?

Guangxi Investment Group Worldwide Filing

Countries in which Guangxi Investment Group Filed Patents

CountryPatents
China143

Where are Research Centers of Guangxi Investment Group Patents Located?

Guangxi Investment Group R&D Centers

10 Best Guangxi Investment Group Patents

CN101752095A is the most popular patent in the Guangxi Investment Group portfolio. It has received 27 citations so far from companies like Sichuan Meijiabao New Energy Technology, Guangdong Yutong Venture Capital and Ruyuan County Lidong Electronic Technology.

Below is the list of 10 most cited patents of Guangxi Investment Group:

Publication NumberCitation Count
CN101752095A27
CN102983008A17
CN101508391A17
CN101740227A14
CN101707141A14
CN201637685U11
CN105420803A10
CN102915847A10
CN201930762U8
CN201896203U7

Guangxi Investment Group focuses its innovation on health and the environment, with an emphasis on medical care, smart healthcare, health tourism, exercise, screen culture, conferences, and exhibitions.

SPF, nginx, and DigiCert SSL are among the technologies used by Guangxi Investment Group.

EXCLUSIVE INSIGHTS COMING SOON!

What are Guangxi Investment Group key innovation segments?

What Technologies are Covered by Guangxi Investment Group?

The chart below distributes patents filed by Guangxi Investment Group different countries on the basis of the technology protected in patents. It also represents the markets where Guangxi Investment Group thinks it’s important to protect particular technology inventions.

R&D Focus: How Guangxi Investment Group search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Guangxi Investment Group?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.